KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells (Q39003629)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 April 2014

Language	Label	Description	Also known as
English	KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells	scientific article published on 16 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Pengliang Shen

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jiabin Sun

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Guiqin Xu

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Li Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Zhaojuan Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Suhua Xia

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yang Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yongzhong Liu

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Guowei Shi

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

16 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

946-958

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Endocrine prevention and treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Effects of the antiandrogen flutamide on the expression of protein kinase C isoenzymes in LNCaP and PC3 human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

The role of antiandrogen monotherapy in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Survivin mediates resistance to antiandrogen therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Mammalian Krüppel-Like Factors in Health and Diseases

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Chromosomal localization and cDNA sequence of human BTEB, a GC box binding protein

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Krüppel-like factor 9 is a circadian transcription factor in human epidermis that controls proliferation of keratinocytes

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Krüppel-like factor KLF9 regulates PPARγ transactivation at the middle stage of adipogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Downregulation of Krüppel-like factor 9 in human colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Prognostic Value and Function of KLF4 in Prostate Cancer: RNAa and Vector-Mediated Overexpression Identify KLF4 as an Inhibitor of Tumor Cell Growth and Migration

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

KLF6, a candidate tumor suppressor gene mutated in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

The emerging role of Krüppel-like factors in endocrine-responsive cancers of female reproductive tissues

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Akt signaling and cancer: surviving but not moving on.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Targeting the PI3K/AKT pathway for the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Androgen Receptor Antagonist versus Agonist Activities of the Fungicide Vinclozolin Relative to Hydroxyflutamide

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Vorinostat and bortezomib synergistically cause ubiquitinated protein accumulation in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22812

21 January 2018

Identifiers

10.1002/PROS.22812

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39003629&oldid=1801756857"